| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | KIDS Orthopediatrics Corp | Bailey David R64 | President And CEO | Sell | 4,052 | $44.40 | $179,910.42 | -3.9% | +0.1% | -38.2% | |
| Mar 6, 2023 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 16,823 | $15.82 | $266,139.86 | -2.3% | -1.7% | -15.8% | |
| Mar 6, 2023 | ENOV Enovis Corp | Shirley Brady60 | Pres. &COO | Sell | 2,102 | $57.69 | $121,264.38 | -3.3% | -3.0% | +8.3% | |
| Mar 3, 2023 | PRCT Procept Biorobotics Corp | Wood Morgan Colby46 | Director | Sell | 15,000 | $36.14 | $542,158.65 | -5.2% | -9.1% | +37.3% | |
| Mar 3, 2023 | RMD Resmed Inc | Ghoshal Kaushik64 | President, Saas Business | Sell | 1,000 | $220.00 | $220,000.00 | -6.0% | -0.5% | -20.6% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 25,635 | $76.16 | $1,952,346.22 | -3.7% | -4.2% | -79.2% | |
| Mar 3, 2023 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,500 | $216.69 | $325,035.00 | -1.6% | -0.5% | -20.6% | |
| Mar 3, 2023 | LMAT Lemaitre Vascular Inc | Kamke Trent G53 | Senior V. P., Operations | Sell | 6,414 | $50.94 | $326,739.42 | -62.9% | +26.3% | +33.3% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Growth Officer | Sell | 21,421 | $76.16 | $1,631,410.51 | -5.0% | -4.2% | -79.2% | |
| Mar 3, 2023 | MMSI Merit Medical Systems Inc | Parra Raul Jr.62 | CFO And Treasurer | Sell | 1,023 | $70.00 | $71,610.00 | -13.3% | +18.3% | +8.8% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Cordova Ashley75 | Chief Financial Officer | Sell | 5,505 | $76.16 | $419,257.50 | -2.6% | -4.2% | -79.2% | |
| Mar 3, 2023 | IRTC Irhythm Holdings, Inc. | Devine Douglas57 | Chief Operating Officer | Sell | 1,473 | $117.23 | $172,679.79 | -4.7% | -7.2% | +1.3% | |
| Mar 3, 2023 | TNDM Tandem Diabetes Care Inc | Berger David B79 | EVP &Chief Operating Officer | Sell | 10,000 | $41.19 | $411,884.00 | -74.8% | -41.0% | -33.7% | |
| Mar 3, 2023 | IRTC Irhythm Holdings, Inc. | Day Mark J.57 | Chief Technology Officer | Sell | 2,116 | $117.23 | $248,058.68 | -3.7% | -7.2% | +1.3% | |
| Mar 3, 2023 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People/ Culture &GC | Sell | 32,823 | $16.00 | $525,168.00 | -2.4% | -4.4% | -16.2% | |
| Mar 3, 2023 | STE Steris Plc | Majors Cary L54 | SVP And President, Healthcare | Sell | 1,150 | $190.21 | $218,741.50 | -9.2% | +6.6% | +22.5% | |
| Mar 3, 2023 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | CLO &EVP Ra/ Qa Mrktacs &Gov | Sell | 571 | $117.23 | $66,938.33 | -1.7% | -7.2% | +1.3% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Burke William Patrick62 | Chief Human Resources Officer | Sell | 593 | $76.16 | $45,162.52 | -0.9% | -4.2% | -79.2% | |
| Mar 3, 2023 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.63 | EVP, Strategy Corp Dev Inv Rel | Sell | 1,422 | $117.23 | $166,701.06 | -3.5% | -7.2% | +1.3% | |
| Mar 3, 2023 | AVTR Avantor, Inc. | Brophy Gerard75 | EVP, Biopharma Production | Sell | 3,914 | $25.00 | $97,850.00 | -3.5% | -20.7% | -0.4% | |
| Mar 3, 2023 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 5,045 | $9.49 | $47,892.19 | -1.5% | +30.7% | -47.3% | |
| Mar 3, 2023 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 3,153 | $9.49 | $29,931.43 | -2.7% | +30.7% | -47.3% | |
| Mar 3, 2023 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 6,268 | $9.49 | $59,502.12 | -0.6% | +30.7% | -47.3% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 2,903 | $76.95 | $223,393.45 | -2.3% | -4.2% | -79.2% | |
| Mar 3, 2023 | PACB Pacific Biosciences Of California, Inc. | Henry Christian O78 | See Remarks | Sell | 13,769 | $9.49 | $130,709.12 | -1.1% | +30.7% | -47.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.